Dr
Amy
Dawson

Trainee Patent Attorney

Glasgow Office

Life sciences

Telephone. +44(0) 141 229 5800
Email. [email protected]

Experience

Amy joined HGF's Glasgow office in May 2020 as a trainee patent attorney within the Life Sciences team.

She graduated from the University of Glasgow in 2016 with a first-class MSci in Immunology with Work Placement. This included a 12-month placement at GlaxoSmithKline R&D. She was awarded the Fyfe & Arthritis Research Campaign Prize for the best final year student in Immunology.

Amy completed a PhD in Cancer Studies from the University of Glasgow in March 2020. Her research involved using single cell RNA sequencing technology and proteomics to investigate the interaction of leukaemic stem cells and immune cells in the cancer microenvironment. During this time she also undertook an internship in technical transfer, which gave her experience in University spin-outs and the process of commercialising novel technologies.

Qualifications

Trainee


MSCI

MSci in Immunology

PHD

PhD in Cancer Sciences

Publications

The EPO ‘How To’ guide for antibody applications in Europe

View publication online

Related News

Food technology companies and investors - the value of IP landscape analysis

Case study – alt fat innovation Many companies and investors are aware of the importance of identifying and protecting their innovations, and in particular of the importance of obtaining patents …

Read article
Event - 29th September 2022

North East Automotive Expo 2022

HGF will be exhibiting at The North East Automotive Alliance’s flagship Expo on 29th September 2022. The event is an industry highlight for companies operating within the region’s automotive supply …

Event details
Event - 21st-22nd September 2022

Medical Technology Ireland 2022

Medical Technology Ireland Conference 2022 will be held on 21-22 September at the Galway Racecource. Medical Technology Ireland is a new high-profile National and International event attracting global suppliers to …

Event details

Artificial intelligence inventions in healthcare – can you patent them in Europe?

Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …

Read article

Patenting digital mental health

Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder [1]. …

Read article

Patenting antibodies in the US and Europe

Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …

Read article

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.